Hi Footmax,
As you well know, you are definitely not al alone in your concerns.From: YEAR END ACCOUNTS AND PRELIMINARY FINAL REPORT (forthe year ended 30 June 2024)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30JUNE 2024
(e) Going concern
….. As at 30 June 2024, the Company had net liabilities of $244,032 and subsequent to year end, the Company entered into a finance facility for an amount of $500,000 which was fully drawn post year end (refer to Note 22). These conditions give rise to a material uncertainty that may cast significant doubt upon the Company’s ability to continue as a going concern.
I've sold my last holdings at a loss. Knowing my luck, the SP will now skyrocket, the options will be exercised and BP will stage gladiator fights to earn the right to back or purchase the business for huge amounts because everyone in the world is now cured of everything courtesy of BIT225. You're welcome!
- Forums
- ASX - By Stock
- BIT
- Ann: Revised Continuous Disclosure Policy
BIT
biotron limited
Add to My Watchlist
0.00%
!
0.2¢

Ann: Revised Continuous Disclosure Policy, page-56
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.654M |
Open | High | Low | Value | Volume |
0.2¢ | 0.2¢ | 0.2¢ | $210 | 104.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
64 | 38848316 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 18281126 | 25 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
59 | 37148316 | 0.002 |
33 | 65631001 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 14162401 | 23 |
0.004 | 12820969 | 17 |
0.005 | 6684000 | 5 |
0.006 | 1200000 | 2 |
0.007 | 1084188 | 2 |
Last trade - 12.28pm 27/06/2025 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online